French Diagnostiscs Company bioMerieux Backs Quanterix
November 19, 2012
Quanterix | Simoa
Quanterix has raised $18.5 million of Series C funding from French diagnostics company bioMérieux, a new investor that contributed $15 million to the round. Previous backers ARCH Venture Partners, Bain Capital Ventures, Flagship Ventures and In-Q-Tel also participated. Founded in 2007, Quanterix is developing a diagnostic platform called the Simoa HD-1 analyzer for measuring individual proteins. The latest financing reportedly values the company at over $100 million.